Delirium Hub: Research

Authors:
BGS Dementia and Related Disorders SIG
British Geriatrics Society
Date Published:
24 November 2021
Last updated: 
24 November 2021

This section of the BGS Delirium Hub examines some of the current research and evidence on delirium.

Interest has been shown in prevention of peri-operative delirium. Non-pharmacological methods have been demonstrated to be beneficial. There may be a role for dexmedetomidine in risk reduction for delirium when compared with other forms of sedation, though this does not replace standard risk reduction and treatment methods.

Systematic review & meta-analysis

Randomised-controlled trials

Observational studies

Reviews

Delirium is common among patients cared for by general physicians. It is associated with worse outcomes and extensive work has been carried out to design methods to detect and treat delirium. The search for a pharmacological treatment for delirium has been elusive. Non-pharmacological methods have an established role.

Systematic review & meta-analysis

Randomised-controlled trials

Many RCTs have been carried out to evaluate the effectiveness of various pharmacological therapies to prevent and treat delirium. Results have been mixed, but in general are reserved to treat distressing symptoms of delirium, with the focus remaining on prevention reversing the underlying cause.

Observational studies

Reviews

Patients admitted to intensive care units are at very high risk of developing delirium. Care is required to reduce the risk of developing delirium and to pro-actively treat it when present.

Systematic review & meta-analysis

Reviews

Delirium has been under-recognised in medical settings. Extensive work has been carried out to design screening tools to improve the detection of delirium.
 

Feedback on this resource?

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.